The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.80
Bid: 33.00
Ask: 34.60
Change: -0.20 (-0.59%)
Spread: 1.60 (4.848%)
Open: 34.00
High: 34.00
Low: 33.80
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant and variation of Options

27 Mar 2024 07:00

RNS Number : 4148I
Mercia Asset Management PLC
27 March 2024
 

RNS

27 March 2024

 

Mercia Asset Management PLC

 

("Mercia", the "Company" or the "Group")

 

Grant and variation of Options

 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£1.5billion of assets under management, announces that options (the "CSOP Options") over a total of 1,000,000 new Ordinary shares ("Ordinary Shares") were awarded to Jocelyne Bath, the new Chief Operating Officer of the Group and a person discharging managerial responsibilities ("PDMR") pursuant to the 2014 Mercia Company Share Option Plan ("2014 CSOP"), at an exercise price of 33.00p per Ordinary Share (being the closing mid-market price of an Ordinary Share on 26 March 2024). The Options will, subject to the satisfaction of the performance condition, vest in three equal tranches on the third, fourth and fifth anniversary of the date of grant of the Options.

 

The Company further announces that, pursuant to the existing 2021 Performance Share Plan, the performance period for the existing 8,800,000 nominal cost options (the "PSP Options") over Ordinary Shares granted on 9 July 2021 to the Executive Directors and one further PDMR, has been extended.

 

Pursuant to the rules of the Mercia CSOP, the Company's Remuneration Committee has elected to vary the vesting period in which the performance condition of the PSP Options has to be satisfied, by an additional year. The Remuneration Committee considers that this is the most appropriate way of continuing to align the interests of the Executive Directors and one further PDMR with the shareholders of the Company, whilst continuing to provide a strong incentive. This facilitates the retention of high calibre individuals, who are leading the delivery of positive investment returns for Mercia's clients and as a direct consequence, the continuing successful growth of Mercia's Assets under Management and its profitability.

The PSP Options will, subject to the satisfaction of the performance condition, now vest on 9 July 2025, being the fourth anniversary of the date of grant of the options (the "Vesting Date") and will continue to be subject to a subsequent two-year holding period. The number of PSP Options which will vest on the Vesting Date will depend on the Company's total shareholder return ("TSR") over a performance period of four financial years, which started on 1 April 2021. The number of PSP Options vesting will be calculated as follows: 50% of the PSP Options will vest based on the achievement of 10.0% TSR per annum (compounded) over the new four-year performance period. Vesting will then increase on a straight-line basis to full vesting for the achievement of 20.0% TSR per annum (compounded). 

 

Following the grant of the CSOP Options and the amendment to the PSP Options above, the Company has a total of 35,039,150 options in issue pursuant to the 2014 CSOP, equating to 8.6% of the existing issued share capital of the Company.

 

Following the grant of the CSOP Options and the amendment to the PSP Options above, the PDMRs listed below hold the following options and Ordinary Shares:

 

PDMR

Role

Grant of CSOP Options or amendment of PSP Options under 2014 CSOP

Total number of options over Ordinary Shares

Interest in existing issued Ordinary Shares

Mark Payton*

Chief Executive Officer

2,596,430

5,422,932

7,184,876

Martin Glanfield**

Chief Financial Officer

2,113,652

4,536,697

1,744,947

Julian Viggars***

Chief Investment Officer

2,113,652

4,536,697

978,640

Peter Dines

Chief Operating Officer

1,976,266

4,245,813

1,078,389

Jocelyne Bath

Chief Operating Officer

1,000,000

1,000,000

-

* Including 12,793 Ordinary shares held by Katharine Yeo

** Including 125,784 Ordinary shares held by Bryonie Glanfield

*** Including 84,064 Ordinary shares held by Emma Viggars

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities:

 

1

Details of the persons discharging managerial responsibilities/person closely associated

a)

Name

(i) Mark Payton, Chief Executive Officer

(ii) Martin Glanfield, Chief Financial Officer

(iii) Julian Viggars, Chief Investment Officer

(iv) Peter Dines, Chief Operating Officer

(v) Jocelyne Bath, Chief Operating Officer

2

Reason for the notification

a)

Position/status

Executive Directors and PDMRs of the Company

b)

Initial Notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Asset Management PLC

b)

Legal Entity Identifier

213800A1Q4CF57NECG66

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.00001 each

 

ISIN - GB00BSL71W47

b)

Nature of transaction

(i) to (iv): variation of performance condition of existing options.

(v): grant of options

c)

Currency

GBP

d)

Price(s) and volume(s)

Exercise Price

No. of Ordinary Shares

£0.00001

(i) 2,596,430

£0.00001

(ii) 2,113,652

£0.00001

(iii) 2,113,652

£0.00001

(iv) 1,976,266

£0.3300

(v) 1,000,000

e)

Aggregate information

- Aggregate volume

- Price

- Aggregate total

N/A - single transactions

f)

Date of the transaction

26 March 2024

g)

Place of the transaction

Outside a trading venue

 

- Ends -

 

For further information, please contact:

 

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

 

+44 (0)330 223 1430

 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel

Singer Capital Markets (Joint Broker)

+44 (0)20 7496 3000

Harry Gooden, James Moat

FTI Consulting

 +44 (0)20 3727 1051

Tom Blackwell, Jenny Boyd

mercia@fticonsulting.com

 

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, private equity, debt and proprietary capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

 

The Group has a strong UK footprint through its regional offices, university partnerships and extensive personal networks, providing it with access to high-quality deal flow.

 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJFMLTMTJTBMI
Date   Source Headline
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board
11th Oct 20167:00 amRNSDigital & Digital Entertainment Portfolio Update
5th Oct 20167:00 amRNSCapital Markets Event
27th Sep 20167:00 amRNSInvestment into innovative healthcare - Medherant
19th Sep 201610:36 amRNSResult of AGM
26th Aug 20167:00 amRNSDirector/PDMR Shareholdings
29th Jul 20167:00 amRNSPublication of Annual Report
28th Jul 20167:00 amRNSGrant Options & PDMR Dealings
26th Jul 20168:30 amRNSRe. Admission to AIM of Concepta PLC
21st Jul 20167:00 amRNSnDreams launches The Assembly for Oculus RIFT
7th Jul 20167:00 amRNSAcquisition, Placing & Open Offer, Change of Name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.